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To the Editor: Since 2007, 
a new cardiovirus, named Saffold 
virus (SAFV), has been isolated from 
human specimens in the United States, 
Canada, the Netherlands, and People’s 
Republic of China (1–4). Concurrent 
investigations also showed that 
SAFV could be detected in feces and 
respiratory secretions of children in 
other countries, and genetic analysis 
showed the circulation of different 
genetic lineages of SAFVs in various 
parts of the world. This new virus 
belongs to the genus Cardiovirus, in 
the family Picornaviridae (5). Here 
we report isolation of a new SAFV in 
Malaysia, designated SAFV-Penang 
to refl ect the locality of isolation in 
Malaysia.
A 5-year-old girl was brought 
to a government outpatient clinic on 
November 18, 2009, with reported 
fever and sore throat for 3 days. The 
fever was described as of high grade 
with occasional episodes of rigor, 
accompanied by profuse sweating 
and myalgia, lethargy, and loss of 
appetite. The child had nasal blockage, 
mild runny nose, and dry cough. She 
vomited twice on day 3 of illness and 
had abdominal pain but no diarrhea. 
There was no history of similar illness 
affecting other family members, who 
lived in a semirural area within the state 
of Penang, Malaysia. Acute pharyngitis/
acute infl uenza-like illness was 
provisionally diagnosed, and a throat 
swab specimen was collected in virus 
transport medium for virus isolation by 
using established procedures (6).
The throat swab sample was 
treated with antimicrobial drugs for 
1 h before the cells were added to 
MDCK, Vero, and Hep-2 cells. On 
the fi fth day postinoculation (dpi), a 
lytic form of cytopathic effect (CPE), 
similar to the type of CPE from 
enterovirus infection, was noted in 
Hep-2 but not in Vero or MDCK cells. 
The progress of CPE was slow, and 
full CPE was achieved on 9 dpi. On 
8 dpi, a 0.5-mL aliquot containing 
infected Hep-2 cell suspension was 
removed and processed for indirect 
immunofl uorescence assay by 
using a panel of commercial typing 
monoclonal antibodies for human 
enteroviruses. The infected Hep-
2 cells reacted strongly with broad 
reactive pan-enterovirus monoclonal 
antibodies (catalog no. 3360, 
Chemicon Inc., Temecula, CA, USA) 
but failed to react with any type-
specifi c monoclonal antibodies (data 
not shown).
After 3 passages in Hep-2 cells, 
culture supernatant was subsequently 
passed into Vero cells. After an 
additional 3 passages, the virus was 
fully adapted to grow in Vero cells and 
was able to induce visible CPE 1 dpi 
and full CPE by 4 dpi.
Partial genome sequence of the 
virus was initially obtained by using 
a random priming and amplifi cation 
method as described (7). Full-length 
sequence was then determined by 
using primers designed according 
to the partial genome sequences of 
SAFV-Penang and genome sequences 
of other SAFV strains available in 
GenBank (primer sequences are 
available on request). The viral 
genome of SAFV-Penang is 8,073 nt 
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(full sequence deposited in GenBank 
under accession no. HQ162476). 
As for other SAFVs, a single long 
open reading frame of 2,295 aa was 
detected. Phylogenetic analysis based 
on the complete amino acid sequences 
of the polyproteins of different SAFVs 
indicated that SAFV-Penang is a 
type 3 SAFV (8). It is most closely 
related to the SAFV-3 isolated in the 
Netherlands in 2007.
To determine the prevalence 
of SAFV infection among children 
in Malaysia, we conducted a 
seroprevalence study by using 400 
serum samples collected during 
2009 from children 10–12 years 
of age under the national hepatitis 
B postvaccination serosurvey. The 
serum panel comprised 80 samples 
containing equal numbers of boys and 
girls from each of the 5 states: Penang 
(northwestern), Selangor (central-
western), and Kelantan (northeastern) 
of peninsular Malaysia, and Sabah 
and Sarawak of eastern Malaysia in 
Borneo Island. Screening for SAFV-
specifi c antibodies was conducted by 
using an indirect immunofl uorescence 
antibody test on SAFV-infected Vero 
cells as described (9). The results 
(Table) indicated that >70% of 
schoolchildren surveyed had been 
exposed to the virus. The seropositive 
rate ranged from 67.5% (Penang) to 
75.0% (Kelantan and Sabah), with no 
signifi cant difference among different 
parts of the country (χ2 = 1.60, df = 4, 
p = 0.8091). The seropositive rate 
did not differ signifi cantly by sex 
(χ2 = 0.32, p = 0.5734).
In summary, a new SAFV was 
discovered in Malaysia by direct virus 
isolation during an investigation of a 
febrile patient. Subsequent serologic 
study indicated that a high percentage 
of children 10–12 years of age had 
been exposed to this virus. Further 
study is required to determine the 
public health implications of SAFV 
infection in Southeast Asia, especially 
in cases in which co-infection with 
other pathogens might potentially lead 
to different clinical outcomes.
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Table. Prevalence of SAFV-specific IgG in serum from children 10–12 years of age, by 





No. positive serum samples†
+ ++ +++ Total no. (%)
Penang 
 M 40 21 7 0 28 (70.0)
 F 40 19 5 2 26 (65.0)
 Total 80 40 12 2 54 (67.5)
Kelantan
 M 40 16 8 5 29 (72.5)
 F 40 18 11 2 31 (77.5)
 Total 80 34 19 7 60 (75.0)
Selangor 
 M 40 16 11 5 32 (80.0)
 F 40 22 5 0 27 (67.5)
 Total 80 38 16 5 59 (73.8)
Sabah 
 M 40 16 9 4 29 (72.5)
 F 40 24 6 1 31 (77.5)
 Total 80 40 15 5 60 (75.0)
Sarawak 
 M 40 22 6 3 31 (77.5)
 F 40 19 5 4 28 (70.0)
 Total 80 41 11 7 59 (73.8)
*SAFV, Saffold virus; Ig, immunoglobulin 
†The degree of positive reactivity was classified into 3 groups: weak (titer <0–40), medium (titer 80–
160), and strong (titer 320–1,280) according to the staining intensity on SAFV-infected Vero cells 
(data not shown). The classification was further confirmed by correlation with virus neutralizing titer 
from 20 samples in each group, with + samples having a titer of 0–40, ++ samples 80–160, and +++ 
samples 320–1,280, respectively.  
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Human Bocavirus 
DNA in Paranasal 
Sinus Mucosa
To the Editor: Human bocavirus 
(HBoV) is a newly described parvovirus 
for which pathogenic potential has 
not clearly been elucidated (1). 
Recent fi ndings suggest that HBoV 
may establish persistent infection of 
mucosal lymphocytes or contribute 
to tonsillar hyperplasia in children 
(2). In previous reports, we described 
prolonged HBoV DNA detection in 
immunocompromised children (3,4). 
Partial sequencing of the VP1 gene of 
HBoV from bronchoalveolar lavage 
fl uid, plasma, and sphenoid sinus 
samples showed 100% identity, which 
suggested persistence of the same 
HBoV strain over a 5-month period 
(3). It remains speculative, however, 
whether paranasal sinus mucosa 
represents a site of HBoV persistence. 
To clarify this, we analyzed samples 
of paranasal mucosal tissue and nasal 
polyps from patients with chronic 
sinusitis for respiratory viruses and 
atypical bacteria.
A total of 102 tissue samples 
were obtained from 88 patients 
(median age 48.5 years, range 13.3–
88.1 years) from July 2009 through 
September 2010 after elective surgery. 
Indication for surgery was established 
by otorhinolaryngologists. The most 
common indication was chronic 
sinusitis. No patients displayed acute 
respiratory symptoms at the time 
of surgery. To detect asymptomatic 
shedding in the upper respiratory 
tract and viremia, we collected nasal 
swabs and EDTA-blood samples 
concurrently. The study protocol was 
approved by the Ethics Committee of 
the University of Freiburg. Informed 
written consent was obtained from all 
study participants.
Approximately 25 mg of each 
tissue specimen was used for nucleic 
acid extraction by using an RNeasy 
Mini Kit, as described (5) (QIAGEN, 
Hamburg, Germany). To provide 
evidence that the QIAGEN RNeasy 
kit is also suitable for DNA extraction, 
we spiked HBoV negative samples 
with different amounts of HBoV DNA 
before extraction of nucleic acids was 
done with either the QIAGEN RNeasy 
Kit or DNA Blood Kit (QIAGEN). 
Extracted nucleic acids were then 
subjected to real-time PCR by using 
primers specifi c for HBoV. Minimal 
differences (±1 cycle threshold 
[Ct] value) in the HBoV PCR were 
detected; the QIAGEN RNeasy Kit 
was therefore used throughout the 
study (data not shown). Nasal swabs 
and EDTA-blood were purifi ed by 
using a QIAamp MinElute Virus 
Spin Kit (QIAGEN). Multiplex PCR 
for respiratory viruses (Fast-track 
Diagnostics, Junglinster, Luxembourg) 
was conducted to detect infl uenza A 
(including pandemic [H1N1] 2009) 
and B viruses; respiratory syncytial 
virus; human metapneumovirus; 
HBoV; parainfl uenza virus 1–4; 
human coronaviruses HKU1, 
NL63, 229E, and OC43; human 
rhinoviruses; human enteroviruses 
and parechoviruses; and adenoviruses. 
Mycoplasma pneumoniae, Chlamydia 
pneumoniae, Legionella pneumophila, 
and Bordetella pertussis were analyzed 
as described (6–8).
A single virus was detected in 
22/102 (21.5%) tissue specimens, 
with HBoV being the most frequent 
(18/102, 17.6%), followed by 
rhinovirus (2/102, 1.9%), coronavirus 
229E, and infl uenza A pandemic 
(H1N1) 2009 virus (1/102, 0.9%). 
HBoV was detected in specimens 
collected during July–September 
(13/18) and during February and 
March (5/18). All positive results 
were confi rmed by single real-time 
PCR (9). For 14 patients, 2 different 
mucosal samples were tested and 
gave identical results. No multiple 
viral infections and no bacteria were 
detected. Median patient age was 
51.2 years (range 14.4–74.2 years) for 
HBoV-positive and 47.6 years (range 
13.3–88.1 years) for HBoV-negative 
samples. Ct analysis in single real-
time PCR revealed a median Ct of 
31 (range 28–38), corresponding to 
200 genome equivalents/106 cells 
(range 3–1.8 × 104 copies/106 cells). 
No correlation between Ct value 
and patients’ age was observed 
(r2 = 0.008; data not shown). No 
underlying disease was diagnosed 
for 13/18 HBoV-positive patients, 
whereas 2/18 and 3/18 patients had 
chronic obstructive pulmonary and 
oncologic disease, respectively.
Nasal swabs and EDTA-blood 
samples were obtained from 17/18 
and 7/18 HBoV-positive patients, 
respectively. No HBoV was detected 
in any swabs or EDTA-blood samples 
available, indicating no virus shedding 
in the respiratory tract and no 
viremia. However, the 2 patients with 
rhinovirus-positive samples obtained 
from biopsy also had rhinovirus RNA 
detectable in nasal swabs, suggesting 
rhinovirus infection. Unfortunately, 
no nasal swab was available from the 
2 patients whose sinus biopsy samples 
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